Literature DB >> 1835129

Orchidectomy or LHRH-analogue? Which do the patients prefer and what treatment would Norwegian urologists prefer if they had advanced cancer of the prostate?

F Samdal1, K Vada, P I Lundmo, O K Mjølnerød.   

Abstract

Since January 1989, we have carried out a prospective study about whether patients prefer orchidectomy or medical castration with luteinising hormone releasing hormone analogues for the treatment of prostatic cancer. When the preliminary results were presented, 40 Norwegian urologists were asked which treatment they would prefer if they had advanced cancer of the prostatic gland. Most patients and urologists (65-70%) favoured medical castration.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1835129     DOI: 10.3109/00365599109107946

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  2 in total

Review 1.  Overview of the current status of total androgen deprivation in metastasized prostate cancer.

Authors:  F M Debruyne; W P Witjes
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

Review 2.  Goserelin. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in prostate cancer.

Authors:  R N Brogden; D Faulds
Journal:  Drugs Aging       Date:  1995-04       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.